Positron-emission tomography with 18F-2-fluoro-2-deoxy-D-glucose (18FDG-PET) in the diagnosis of retroperitoneal lymph-node metastases from testicular tumors;Die positronenemissionstomographie mit [18 F]-2-fluoro-2-deoxy-D- glucose (18FDG-PET) bei der diagnostik retroperitonealer lymphknotenmetastasen von hodentumoren

Urologe - Ausgabe A

Volumn 37, Issue 6, 1998, Pages 609-620

  Muller Mattheis V ^a   Reinhardt, M ^a   Gerharz, C D ^a   Furst G ^a   Vosberg, H ^a   Muller Gartner H W ^a,b   Ackermann, R ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b FORSCHUNGSZENTRUM JÜLICH   (Germany)

Author keywords

Fluorodeoxyglucose; Lymph node metastases; Positron emission tomography; Testicular cancer

Indexed keywords

CARBOPLATIN; FLUORODEOXYGLUCOSE F 18; DIAGNOSTIC AGENT; TUMOR MARKER;

ARTICLE; CANCER STAGING; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; GANGLIONEUROMA; HISTOPATHOLOGY; HUMAN; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PARAAORTIC LYMPH NODE; POSITRON EMISSION TOMOGRAPHY; SEMINOMA; TESTIS TUMOR; ADULT; BLOOD; COMPUTER ASSISTED EMISSION TOMOGRAPHY; FOLLOW UP; LYMPH NODE; METASTASIS; MIDDLE AGED; NEOPLASM; PATHOLOGY; PROGNOSIS; RETROPERITONEAL TUMOR; SCINTISCANNING; SENSITIVITY AND SPECIFICITY;

ADULT; FLUORODEOXYGLUCOSE F18; FOLLOW-UP STUDIES; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM STAGING; NEOPLASMS, GERM CELL AND EMBRYONAL; PROGNOSIS; RETROPERITONEAL NEOPLASMS; SEMINOMA; SENSITIVITY AND SPECIFICITY; TESTICULAR NEOPLASMS; TOMOGRAPHY, EMISSION-COMPUTED; TUMOR MARKERS, BIOLOGICAL;

EID: 0031798156     PISSN: 03402592     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001200050223     Document Type: Article

References (58)

1. Adler LP, Blair HF, Makley JT, Williams RP, Joyce MJ, Leisure G, Al-Kaisi N, Miraldi F (1991) Non-invasive grading of musculoskeletal tumors using PET. JNM 32: 1508-1512
2. Aprikian AG, Herr HW, Bajorin DF, Bosl GJ (1994) Resection of postchemotherapy residual masses and limited retroperitoneal lymphadenectomy in patients with metastatic testicular nonseminomatous germ cell tumors. Cancer 74: 1329-1334
3. Baniel J, Foster RS, Rowland RG, Bihrle R, Donohue JP (1994) Complications for primary retroperitoneal lymph node dissection. J Urol 152: 424-427
4. Baniel J, Foster RS, Rowland RG, Bihrle R, Donohue JP (1995) Complications of postchemotherapy retroperitoneal lymph node dissection. J Urol 153:976-980
5. Beaney RP (1984) Positron emission tomography in the study of human tumors. Semin Nucl Med 14: 324-341
6. Bihrle R, Donohue JP, Foster RS (1988) Complications of retroperitoneal lymph node dissection. Urol Clin North Am 15: 237-242
7. Daghighian F, Sumida R, Phelps ME (1990) PET imaging: an overview and instrumentation. J Nucl Med Technol 18: 5-13
8. Di Chiro G, DeLaPaz RL, Brooks RA, Sokoloff L, Kornblith PL, Smith BH, Patronas NJ, Kufta CV, Kessler RM, Johnston GS, Manning RG, Wolf AP (1982) Glucose utilisation of cerebral gliomas measured by [18F]fluorodeoxyglucose and positron emission tomography. Neurology 32: 1323-1329
9. Di Chiro G (1986) Positron emission tomography using 18F-fluorodeoxyglucose in brain tumors. A powerful diagnostic and prognostic tool. Invest Radiol 22: 360-371
10. Donohue JP, Foster RG, Rowland RG, Bihrle R, Jones J, Geier G (1990) Nerve-sparing retroperitoneal lymphadenectomy with preservation of ejaculation. J Urol 144: 287-292
11. Effert P, Cremenus U, Adam G, Wolff J, Thill R, Bull U, Jakse G (1997) Positronen-Emissions-Tomographie (PET) zur Therapiekontrolle metastasierter Hodentumoren nach Chemotherapie. Urologe [A] 36 [Suppl]: 67
12. Fernandez EB, Moul JW, Foley JP, Colon E, McLeod DG (1994) Retroperitoneal imaging with third and fourth generation computed axial tomography in clinical stage I nonseminomatous germ cell tumors. Urology 44:548-552
13. Fischman AJ, Alpert NM (1993) FDG-PET in oncology. There's more to it than looking at pictures. J Nucl Med 34: 6-11
14. Fossa SD, Ous S, Lien HH, Stenwig AE (1989) Post-chemotherapy lymph node histology in radiologically normal patients with metastatic nonseminomatous testicular cancer. J Urol 141: 557-559
15. Fossa SD, Qvist H, Stenwig AE (1992) Is post-chemotherapy retroperitoneal surgery necessary in patients with nonseminomatous testicular cancer and minimal residual tumor mass? J Clin Oncol 10: 569-573
16. Haberkorn U, Strauss LG, Dimitrakopoulou A, Seiffert E, Oberdorfer F, Ziegler S, Reisser C, Doll J, Helus F, van Kaick G (1993) Fluorodeoxyglucose imaging of advanced head and neck cancer after chemotherapy. J Nucl Med 34: 12-17
17. Hamacher K, Coenen HH, Stoecklin G (1986) Efficient stereospecific synthesis of nocarrier added 2-[F-18]fluoro-2-deoxy-D-glucose using aminopolyether-supported nucleophilic substitution. JNM 27: 235-238
18. Hamacher K, Blessing G, Nebeling B (1990) Computer-aided synthesis (CAS) of no-carrier added 2-[18F]fluoro-2-deoxyglucose: an efficient automated system for the aminopolyether-supported nucleophilic fluorination. Appl J Radiat Isot 41: 49-65
19. Hawkins RA, Hoh C, Glaspy J, Choi Y, Dahlbom M, Rege S, Messa C, Nietszche E, Huffman E, Seeger L, Maddahi J, Phelps ME (1989) The role of positron emission tomography in oncology and other whole-body applications. Semin Nucl Med 22: 268-284
20. Hawkins RA, Choi Y, Huang S-C, Messa C, Hoh CK, Phelps ME (1992) Quantitating tumor glucose metabolism with FDG and PET. J Nucl Med 33: 339-344
21. Heicappell R, Müller-Mattheis V, Buszello H, Mecklenbeck W, Feinendegen L, Ackermann R (1992) Detection of lymph node metastases of urological neoplasms by positron emission tomography (PET). Posterprasentation am 24 Juli 1992, X. Congress of the European Association of Urology, 21.-25.7. 1992, Genua/Italien (prize for the best contribution on Urological Oncology)
22. Herr HW, Sheinfeld J, Puc HS, Heelan R, Bajorin DF, Mencel P, Bosl GJ, Motzer RJ (1997) Surgery for a post-chemotherapy residual mass in seminoma. J Urol 157: 860-862
23. Hilton S, Herr HW, Teitcher JB, Begg CB, Castellino RA (1997) CT detection of retroperitoneal lymph node metastases in patients with clinical stage I testicular nonseminomatous germ cell cancer: assessment of size and distribution criteria. AJR 169: 521-525
24. Leibovitch I, Foster RS, Kopecky KK, Donohue JP (1995) Improved accuracy of computerized tomography based clinical staging in low stage nonseminomatous germ cell cancer using size criteria of retroperitoneal lymph nodes. J Urol 154: 1759-1763
25. Logothetis CJ, Samuels ML, Trinade A, Johnson DE (1982) The growing teratoma syndrome. Cancer 50: 1629-1635
26. Mecklenbeck W, Reinhardt M, Müller-Mattheis V, Heicappell R, Wirrwar A, Vosberg H (1993) Messung des 18F-FDG Uptakes zur verbesserten Identifikation und Abgrenzung urologischer Tumoren und Metastasen. Nuklearmedizin 32: A 39
27. Mecklenbeck W, Heicappell R, Reinhardt M, Müller-Mattheis V, Vosberg H, Ackermann R, Müller-Gärtner H-W (1993) Detection of lymph node metastases of urologic tumors by 18F-FDG PET. Eur J Nucl Med 20: 829
28. Minn H, Paul X, Ahonen A (1988) Evaluation of treatment response to radiotherapy in head and neck cancer with fluorine-18-fluorodeoxyglucose. JNM 29: 1521-1525
29. Minn H, Joensuu H, Ahonen A, Klemi P (1988) Fluorodeoxyglucose imaging: a method to assess the proliferative activity of human cancer in vivo. Cancer 61: 1776-1781
30. Munechika H, Cohan RH, Dunnick NR (1988) Non-seminomatous testicular tumors: effect of lesion side on CT detection of lymph node metastasis. Comp Med Im Graph 12: 343-348
31. Müller-Mattheis V, Reinhardt M, Muller-Gartner H-W, Ackermann R (1994) Erfassung von Lymphknotenmetastasen urologischer Malignome durch die Positron-Emissionstomographie (PET) mit Fluordeoxyglukose (18F-FDG). Urologe [A] 33 [Suppl]: 29
32. Muller-Mattheis V, Reinhardt M, Muller-Gartner H-W, Ackermann R (1995) Metabolisches Imaging von Lymphkotenmetastasen urologischer Karzinome durch die Positronen-Emissionstomographie (18F-FDG-PET). Endoskopie Heute 8: 78-79
33. Muller-Mattheis V, Reinhardt M, Vosberg H, Muller-Gärtner H-W, Ackermann R (1996) Untersuchung von retroperitonealen Lymphknotenmetastasen bei Hodentumoren mit der Positronen-Emissionstomographie (18F-FDG-PET). Urologe [A] 35 [Suppl]: 106
34. Muller-Mattheis V, Reinhardt M, Vosberg H, Müller-Gartner H-W, Ackermann R (1997) Bedeutung der Positronen-Emissionstomographie (18F-FDG-PET) bei der Diagnostik von Lymphknotenmetastasen maligner Hodentumoren. Urologe [A] 36 [Suppl]: 68
35. Nuutinen JM, Leskinen S, Elomaa I, Minn H, Varpula M, Solin O, Söderstrom K-O, Joensuu H, Salminen E (1997) Detection of residual tumours in postchemotherapy testicular cancer by FDG-PET. Eur J Cancer 33: 1234-1241
36. Panicek DM, Toner GC, Eelan RT, Bosl GJ (1990) Nonseminomatous germ cell tumors: enlarging mass despite chemotherapy. Radiology 175: 499-502
37. Pizzocaro G, Zanoni F, Salvioni R, Milani A, Piva L (1985) Surveillance or lymph node dissection in clinical stage 1 nonseminoma tous germinal testis cancer? Br J Urol 5: 759-762
38. Pizzocaro G, Zanoni F, Salvioni R, Milani A, Piva L, Pilotti S (1987) Difficulties of surveillance study omitting retroperitoneal lymphadenectomy in clinical stage I nonseminomatous germ cell tumors of the testis. J Urol 138: 1393-1396
39. Pizzocaro G (1987) Retroperitoneal lymph node dissection in clinical stage II A and II B nonseminomatous germ cell tumors of the testis. Int J Androl 10: 269-272
40. Qvist HL, Fossa SD, Ous S, Hoie J, Stenwig AE, Giercksky K-E (1991) Postchemotherapy tumor residuals in patients with advanced nonseminomatous testicular cancer. Is it necessary to resect all residual masses? J Urol 145: 300-303
41. Reinhardt M, Müller-Mattheis V, Vosberg H, Ackermann R, Müller-Gärtner H-W (1995) Staging of lymph nodes in testicular cancer by FDG-PET. Eur J Nucl Med 22: 804
42. Reinhardt M, Müller-Mattheis V, Larisch R, Vosberg H, Ackermann R, Muller-Gärtner H-W (1995) Time activity analysis improves specificity of FDG-PET in staging of pelvic lymph node metastases. Eur J Nucl Med 22: 803
43. Reinhardt M, Müller-Mattheis V, Vosberg H, Ackermann R, Müller-Gärtner H-W (1997) Staging retroperitonealer Lymphknoten bei Hodenkrebs mit FDG-PET. Nuklearmedizin 36: A 33
44. Reinhardt MJ, Muller-Mattheis VGO, Gerharz CD, Vosberg H, Ackermann R, Muller-Gartner H-W (1997) FDG-PET evaluation of retroperitoneal metastases of testicular cancer before and after chemotherapy. JNM 38: 99-101
45. Rigo P, Paulus P, Kaschten BJ, Hustinx R, Bury T, Jerusalem G, Benoit T, Foidart-Willems J (1996) Oncological applications of positron emission tomography with fluorine-18fluorodeoxyglucose. Eur J Nucl Med 23 1641-1674
46. Rozenthal JM, Levine RL, Nickles RJ, Dobkin JA (1989) Glucose uptake by gliomas after treatment. A positron emission tomographic study. Arch Neurol 46: 1302-1307
47. Stephens AW, Gonin R, Hutchins GD, Einhorn LH (1996) Positron emission tomography evaluation of residual radiographic abnormalities in postchemotherapy germ cell tumor patients. J Clin Oncol 14: 1637-1641
48. Stomper PC, Fung CY, Socinsky MA, Jochelson MS, Garnick MB, Richie JP (1987) Detection of retroperitoneal metastases in early-stage nonseminomatous testicular cancer: analysis of different CT criteria. AJR 149: 1187-1190
49. Strauss LG, Clonus JH, Schlag P, Lehner B, Kimmig B, Engenhart R, Marin-Grez M, Helus F, Oberdorfer F, Schmidlin P, van Kaick G (1989) Recurrence of colorectal tumors: PET evaluation. Radiology 170: 329-332
50. Strauss LG, Conti PS (1991) The applications of PET in clinical oncology. JNM 32. 623-648
51. Strauss LG (1996) Fluorine-18 deoxyglucose and false-positive results: a major problem in the diagnostics of oncological patients. Eur J Nucl Med 23: 1409-1415
52. Wahl RL, Kaminski RS, Ethier SP, Hutchins GD (1990) The potential of 2-deoxy-2[18F]fluoro-D-glucose (FDG) for the detection of tumor involvement in lymph nodes. J Nucl Med 31: 1831-1835
53. Wahl RL, Greenough R, Clark MF, Grossman HB (1993) Initial evaluation of FDG/PET imaging of metastatic testicular neoplasms. JNM 34. 6P
54. Warburg O, Wind F, Neglers E (1930) On the metabolism of tumors in the body. In: Warburg O (ed) Metabolism of tumors. Constable, London, pp 254-270
55. Warburg O (1931) The metabolism of tumors. Smith, New York, NY, pp 129-169
56. Weinhouse S (1976) The Warburg hypothesis fifty years later. Z Krebsforsch 87: 115-126
57. 18FDG positron emission tomography: prospects for detection and management. Eur J Nucl Med 22: 508-513
58. Wood DP, Herr HW, Heller G, Vlamis V, Sogani PC, Motor RJ, Fair WR, Bosl GJ (1992) Distribution of retroperitoneal metastases in patients with nonseminomatous germ cell tumors. J Urol 148: 1812-1816